For Press Inquiries, please contact:

Ariela Weinberger
Communications Manager
aweinberger@rooseveltinstitute.org

FOR IMMEDIATE RELEASE: July 30, 2019 CONTACT: Kendra Bozarth, kbozarth@rooseveltinstitute.org Reviving Industrial Policy and Economy-Wide Planning in the Time of Global Crises New Roosevelt report explores the role of democratic industrial policy in tackling America’s greatest global threats The US faces numerous challenges—from climate change to trade competition—that make a more robust industrial policy and

FOR IMMEDIATE RELEASE: July 24, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org Roosevelt Network Launches Annual Emerging Fellows Research Program New student-led research focuses on climate change, social justice, and the opioid epidemic Today, the Roosevelt Network launched the latest research papers from its Emerging Fellowship program, a yearlong opportunity for college students to dig deeper into

FOR IMMEDIATE RELEASE: July 23, 2019 STATEMENT: Roosevelt Network Will No Longer Support Foreign Policy Proposals and Projects New York, NY—To better support student policymakers and activists at the state and local levels, the Roosevelt Network is moving away from supporting foreign policy proposals and projects for its 10 Ideas publication. “We want our students

Tagged under: ,

FOR IMMEDIATE RELEASE: July 18, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org STATEMENT: Roosevelt Institute Experts Respond to Stop Wall Street Looting Act NEW YORK, NY—Today, Senators Elizabeth Warren (D-MA), Tammy Baldwin (D-WI), Kirsten Gillibrand (D-NY), and Sherrod Brown (D-OH) released the Stop Wall Street Looting Act, a bill to curb private equity (PE) firms’ most egregious

Tagged under:

FOR IMMEDIATE RELEASE: July 11, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org Rising Number of Hospital Mergers and Closures in Rural America Hurting Women’s Health, Economic Well-Being Roosevelt Institute documents adverse effects of market power crisis An issue brief released today by the Roosevelt Institute finds that corporate consolidation within America’s rural hospital sector is harming both

FOR IMMEDIATE RELEASE: July 8, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org How Philanthropy Can Address the Racial Wealth Gap  A new report explores the evolution of the Ford Foundation’s work on the racial wealth gap and provides recommendations for how the philanthropic sector can more effectively address the issue Today, the Roosevelt Institute released a report

FOR IMMEDIATE RELEASE: June 19, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org The High Cost of Shareholder Power in Big Pharma New Roosevelt brief illustrates the magnitude of Big Pharma spending on shareholders NEW YORK, NY – At a time when Americans pay record prices for medications, pharmaceutical companies generate record profits devoted largely to rewarding shareholders

FOR IMMEDIATE RELEASE: June 19, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org Toward a Just Economy: How a Universal Basic Income Can Curb Racial Inequality Coinciding with Juneteenth and the presidential debates, a new issue brief explores the role of guaranteed income in combating racial wealth inequalities NEW YORK, NY – A new issue brief released today

FOR IMMEDIATE RELEASE: June 14, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org The Role of the Economy in Combating Climate Change New Roosevelt Institute report outlines an economic policy framework to address climate change while promoting growth and ensuring equitable economic outcomes NEW YORK, NY – The United States needs a new approach to climate change—one that

FOR IMMEDIATE RELEASE: May 22, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org Capturing the Government: Big Pharma’s Take Over of Policymaking New brief explores how drug companies influence policymakers and the resulting harm in patient outcomes Today, the Roosevelt Institute released the issue brief, “The Cost of Capture: How the Pharmaceutical Industry has Corrupted Policy Makers and